Gianni Gori Savellini

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 19

Top Venues

Viruses

Vaccines

Pathogens (Basel, Switzerland)

PLoS pathogens

University of Siena

University of Siena (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Siena

Italy

Research fellows :: Medical Biotechnologies

Azienda Ospedaliera Universitaria Senese

Italy

Fellowship :: Medical Biotechnologies

Italian Society for Virology

Italy

Fellowship :: Medical Biotechnologies

Education History

University of Siena Jul 21 2008

Italy

MSC :: Medical Biotechnologies, Microbiology section

University of Siena

Italy

PHD :: Medical Biotechnologies

Publications

Gianni Gori Savellini, Gabriele Anichini, Fabrizio Manetti, Claudia Immacolata Trivisani, Maria Grazia Cusi
Deletion of 82-85 N-Terminal Residues in SARS-CoV-2 Nsp1 Restricts Virus Replication. Viruses 16 (5) (2024)
Gianni Gori Savellini, Gabriele Anichini, Fabrizio Manetti, Claudia Immacolata Trivisani, Maria Grazia Cusi
Deletion of 82-85 N-Terminal Residues in SARS-CoV-2 Nsp1 Restricts Virus Replication. Viruses 16 (5) (2024)
Gianni Gori Savellini, Gabriele Anichini, Fabrizio Manetti, Claudia Immacolata Trivisani, Maria Grazia Cusi
Deletion of 82-85 N-Terminal Residues in SARS-CoV-2 Nsp1 Restricts Virus Replication. Viruses 16 (5) (2024)
Gianni Gori Savellini, Gabriele Anichini, Fabrizio Manetti, Claudia Immacolata Trivisani, Maria Grazia Cusi
Deletion of 82-85 N-Terminal Residues in SARS-CoV-2 Nsp1 Restricts Virus Replication. Viruses 16 (5) (2024)
Maria Grazia Cusi, Anna Maria Di Giacomo, Gabriele Anichini, Gianni Gori Savellini, Chiara Terrosi, Claudia Gandolfo, Michele Maio
Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID. Viruses 15 (3) (2023)
Maria Grazia Cusi, Anna Maria Di Giacomo, Gabriele Anichini, Gianni Gori Savellini, Chiara Terrosi, Claudia Gandolfo, Michele Maio
Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID. Viruses 15 (3) (2023)
Maria Grazia Cusi, Anna Maria Di Giacomo, Gabriele Anichini, Gianni Gori Savellini, Chiara Terrosi, Claudia Gandolfo, Michele Maio
Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID. Viruses 15 (3) (2023)
Claudia Gandolfo, Gabriele Anichini, Marco Mugnaini, Monica Bocchia, Chiara Terrosi, Anna Sicuranza, Gianni Gori Savellini, Alessandro Gozzetti, Federico Franchi, Maria Grazia Cusi
Overview of Anti-SARS-CoV-2 Immune Response Six Months after BNT162b2 mRNA Vaccine. Vaccines 10 (2) (2022)
Gabriele Anichini, Chiara Terrosi, Gianni Gori Savellini, Claudia Gandolfo, Francesca Barbagli, Giulio Alberto Carta, Simonetta Fabrizi, Giovanni Battista Miceli, Maria Grazia Cusi
Antibody Response against Circulating Omicron Variants 8 Months after the Third Dose of mRNA Vaccine. Vaccines 10 (9) (2022)
Claudia Gandolfo, Chiara Terrosi, Shibily Prathyumnan, Gabriele Anichini, Gianni Gori Savellini, Giuseppe Morgante, Maria Grazia Cusi
Human Polymorphonuclear Cells Support Zika Virus to Cross Endothelial Monolayer and Access Bloodstream. Pathogens (Basel, Switzerland) 11 (3) (2022)
Gabriele Anichini, Chiara Terrosi, Claudia Gandolfo, Gianni Gori Savellini, Simonetta Fabrizi, Giovanni Battista Miceli, Federico Franchi, Maria Grazia Cusi
Omicron Infection Evokes Cross-Protection against SARS-CoV-2 Variants in Vaccinees. Vaccines 10 (5) (2022)
Gianni Gori Savellini, Gabriele Anichini, Claudia Gandolfo, Maria Grazia Cusi
Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-β and IL-6 Secretion. Viruses 14 (6) (2022)
Claudia Gandolfo, Shibily Prathyumn, Chiara Terrosi, Gabriele Anichini, Gianni Gori Savellini, Davide Corti, Luisa Bracci, Antonio Lanzavecchia, Gleyder Roman-Sosa, Maria Grazia Cusi
Identification of a Neutralizing Epitope on TOSV Gn Glycoprotein. Vaccines 9 (8) (2021)
Chiara Terrosi, Gabriele Anichini, Jean Denis Docquier, Gianni Gori Savellini, Claudia Gandolfo, Francesco Saverio Pavone, Maria Grazia Cusi
Efficient Inactivation of SARS-CoV-2 and Other RNA or DNA Viruses with Blue LED Light. Pathogens (Basel, Switzerland) 10 (12) (2021)
Gabriele Anichini, Chiara Terrosi, Gianni Gori Savellini, Claudia Gandolfo, Federico Franchi, Maria Grazia Cusi
Neutralizing Antibody Response of Vaccinees to SARS-CoV-2 Variants. Vaccines 9 (5) (2021)
Gianni Gori Savellini, Gabriele Anichini, Claudia Gandolfo, Maria Grazia Cusi
SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity. Viruses 13 (8) (2021)
Gabriele Anichini, Claudia Gandolfo, Simonetta Fabrizi, Giovan Battista Miceli, Chiara Terrosi, Gianni Gori Savellini, Shibily Prathyumnan, Daniela Orsi, Giuseppe Battista, Maria Grazia Cusi
Seroprevalence to Measles Virus after Vaccination or Natural Infection in an Adult Population, in Italy. Vaccines 8 (1) (2020)
Gianni Gori Savellini, Luca Bini, Assunta Gagliardi, Gabriele Anichini, Claudia Gandolfo, Shibily Prathyumnan, Maria Grazia Cusi
Ubiquitin and Not Only Unfolded Domains Drives Toscana Virus Non-Structural NSs Protein Degradation. Viruses 12 (10) (2020)
Gianni Gori Savellini, Gabriele Anichini, Claudia Gandolfo, Shibily Prathyumnan, Maria Grazia Cusi
Toscana virus non-structural protein NSs acts as E3 ubiquitin ligase promoting RIG-I degradation. PLoS pathogens 15 (12) (2019)

Gianni Gori Savellini.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Gianni Gori Savellini